… compared with gefitinib and icotinib (P<0.05). In conclusion, gefitinib, erlotinib and icotinib
had … However, gefitinib resulted in a lower frequency of fatigue, and nausea and vomiting, …

… gefitinib, erlotinib, afatinib, dacomitinib, or icotinib had a higher probability of experiencing
an event; conversely, a hr less than 1.0 suggests that patients receiving erlotinib or gefitinib …

… indicated that erlotinib, gefitinib, afatinib and icotinib shared … Erlotinib and afatinib revealed
potentially better efficacy but significant higher toxicities compared with gefitinib and icotinib…

… gefitinib vs. chemotherapy in EGFR-mutant patients with completely resected NSCLC confirmed
that adjuvant gefitinib … EGFR-TKIs included icotinib, erlotinib and gefitinib. Previous trial …

… , we found that gefitinib penetrated the blood-… erlotinib or icotinib in a nude mouse model.
The 1-h ratio of brain metastases to plasma concentration for gefitinib, erlotinib, and icotinib …

… Gefitinib and erlotinib are EGFR TKIs that were shown to greatly improve clinical outcomes
and safety when compared with chemotherapy or placebo in second-line or further-line …

… icotinib arm and 2 in the gefitinib arm. These results indicated that icotinib was as efficacious
as gefitinib … is cheaper than any other targeted agents such as gefitinib, erlotinib and afatinib…

… (ICOGEN), which showed icotinib is noninferior to gefitinib. This review will discuss the role
of … In this study, the quality-adjusted life years (QALYs) for icotinib, gefitinib and erlotinib were …

… the inhibitory effects of icotinib and erlotinib against UGT1A1, as … icotinib and erlotinib are
UGT1A1 inhibitors, but the inhibitory effect of icotinib on UGT1A1 is weaker than that of erlotinib…

… A new method for the simultaneous analysis of five EGFR-TKIs (afatinib, erlotinib, gefitinib,
icotinib and osimertinib) and their metabolites in human plasma samples was developed and …